Zhao_2017_Med.Sci.Monit_23_3311

Reference

Title : Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia - Zhao_2017_Med.Sci.Monit_23_3311
Author(s) : Zhao FC , Wu Y , Song XJ
Ref : Med Sci Monit , 23 :3311 , 2017
Abstract :

BACKGROUND Cognitive decline (e.g., memory loss), which mainly occurs in the elderly, is termed dementia. In the present study, we intended to explore the cholinesterase inhibitory activity of some novel synthesized chalcones, together with their effect on beta-amyloid anti-aggregation. MATERIAL AND METHODS A novel class of chalcone derivatives have been synthesized and characterized by FT-IR, (1)H-NMR, (1)(3)C-NMR, and mass and elemental analysis. These derivatives were later used for the determination of acetylcholinesterase (AChE) inhibitory and b-amyloid anti-aggregation activity. RESULTS The results of the study showed that among the developed compounds, 8g inhibits AChE more prominently than BuChE, as suggested by a selectivity index (SI) of 2.88. Furthermore, the most potent compound, 8g, showed considerable action in inhibition of beta-secretase and Abeta aggregation, but not as prominent as that of curcumin as a standard. CONCLUSIONS In conclusion, our study revealed a novel class of chalcone derivatives as a selective inhibitor of AChE with considerably action against beta-secretase and Abeta aggregation. Our results may be useful in developing AD drug therapy and warrant further investigation to generate more advanced analogues.

PubMedSearch : Zhao_2017_Med.Sci.Monit_23_3311
PubMedID: 28687725

Related information

Citations formats

Zhao FC, Wu Y, Song XJ (2017)
Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia
Med Sci Monit 23 :3311

Zhao FC, Wu Y, Song XJ (2017)
Med Sci Monit 23 :3311